A clearer picture

A definitive answer on metformin, more detail on SGLT-2 inhibitors and the best combinations of lipid-lowering drugs are among the unknowns in cardiovascular risk reduction in diabetes that Professor Miles Fisher would like to see answered.

For more from Professor Fisher, enrol on the EASD e-Learning course ‘Cardiovascular health and diabetes’.